arabinofuranosylcytosine triphosphate has been researched along with Hepatitis B in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kang, MJ; Kim, DH; Lee, HS; Lee, J; Yoo, BC; Yoo, HH; Yoo, HW | 1 |
1 trial(s) available for arabinofuranosylcytosine triphosphate and Hepatitis B
| Article | Year |
|---|---|
Rapid quantitative determination of L-FMAU-TP from human peripheral-blood mononuclear cells of hepatitis B virus-infected patients treated with L-FMAU by ion-pairing, reverse-phase, liquid chromatography/electrospray tandem mass spectrometry.
Topics: Adult; Antiviral Agents; Arabinofuranosylcytosine Triphosphate; Arabinofuranosyluracil; Chromatography, High Pressure Liquid; Half-Life; Hepatitis B; Humans; Mass Spectrometry; Middle Aged; Reproducibility of Results | 2006 |